J&J innovation arm backs biotech company's $60.75M funding round

Johnson & Johnson Innovation joined in the $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.

SonoThera created an ultrasound-guided, non-viral gene therapy platform designed to provide patients with genetic medicines via sonoporation. The financing will be used to support the continued development of the platform, according to a Dec. 5 SonoThera news release. 

The round was led by Arch Venture Partners.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars